Pharmaceutical manufacturing
Auronova — next-generation API manufacturing in Himachal Pradesh
Auronova Limited is developing a state-of-the-art Active Pharmaceutical Ingredient (API) manufacturing facility in India, designed to meet domestic and global pharmaceutical demand in compliance with international regulatory standards.
Promoted by professionals with significant experience in pharmaceutical manufacturing, regulated environments, and industrial project execution, Auronova aims to build a cGMP-compliant, environmentally responsible, and globally competitive API platform.
About AuronovaProject snapshot
Auronova facility overview
A multipurpose API manufacturing facility designed for both domestic and international markets, developed within India's Bulk Drug Park ecosystem.
Location
Una Bulk Drug Park, Himachal Pradesh
Facility type
Multipurpose API manufacturing unit
Compliance
Designed as per cGMP standards
Market focus
Domestic & export
Direction
Our vision for Auronova
To establish Auronova as a globally trusted API manufacturing company through quality, compliance, and operational excellence.
- cGMP guidelines from the ground up
- International pharmacopoeia standards (IP / BP / USP / EP)
Commitment
Our mission
- Build a world-class API manufacturing facility
- Ensure regulatory readiness from day one
- Adopt sustainable and efficient manufacturing practices
- Serve global pharmaceutical markets with high-quality APIs
CMO & CDMO
Partnering for progress with Auronova
We assist partners in turning ideas into reality — from early-stage research to large-scale production — with collaborative roadmaps and compliance-first execution.
Custom synthesis
Complex molecules for R&D, clinical trial APIs, intermediates, and scale-up.
Learn moreProcess development
Efficient synthetic routes, scale-up, validation, and process refinement.
Learn moreCommercial manufacturing
GMP-aligned production with adaptable services for evolving requirements.
Learn moreAnalytical development
Method development, validation, impurity profiling, and stability studies.
Learn moreFAQ
Common questions about Auronova
Straight answers for partners, investors, and anyone searching for Auronova Limited or Auronova Group.
What is Auronova Limited?
Auronova Limited is a pharmaceutical company developing a modern, cGMP-designed multipurpose API manufacturing facility at Una Bulk Drug Park, Himachal Pradesh. The company is also known as Auronova Group.
Where is the Auronova facility located?
The facility is being developed at Una Bulk Drug Park in Himachal Pradesh, within a government-supported Bulk Drug Park ecosystem that provides shared infrastructure and regulatory support.
Does Auronova offer CDMO or CMO services?
Yes. Auronova is building a platform for contract development and manufacturing (CMO/CDMO), spanning custom synthesis, process development, commercial manufacturing, and analytical development.
What quality standards is Auronova designing for?
The facility is being designed to align with cGMP guidelines and international pharmacopoeia standards including IP, BP, USP, and EP — with quality systems established from the earliest stages of development.
Get in touch with Auronova
For partnership enquiries, investor updates, or general information, reach our team at Una Bulk Drug Park.